Kaplan-Meier survival analysis revealed that the expression levels of ANLN, BMP2, CALU, COL1A1, COL1A2, COL3A1, ERO1A, FSCN1, FZD3, LOXL2, MME, MSI2, NFIX, PTX3, RTKN2, SLC2A1, SLC16A1, and SNX30 were relevant with poor prognosis in NSCLC patients (Figure 7). The gene discussed is NFIX; the disease is non-small cell lung carcinoma.